Standardizing On Veeva Systems, Inc. Vault Enhances Regeneron???s Clinical And Regulatory Operations Processes Post author:Sam Post published:June 18, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like BioNTech Release: MammaTyper Enables More Precise Prediction Of The Response To Neoadjuvant Chemotherapy Compared To Manual Or Digitalized IHC February 14, 2017 Janssen R&D Release: Data At ASCO Show Consistent Progression-Free Survival Benefit In Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients Treated With Ibrutinib, Including Those With High-Risk Disease, With Up To Four Years Of Follow-Up June 4, 2017 Pfizer Makes a $545 Million Deal With Another Bay Area Biotech, Sangamo May 10, 2017
BioNTech Release: MammaTyper Enables More Precise Prediction Of The Response To Neoadjuvant Chemotherapy Compared To Manual Or Digitalized IHC February 14, 2017
Janssen R&D Release: Data At ASCO Show Consistent Progression-Free Survival Benefit In Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients Treated With Ibrutinib, Including Those With High-Risk Disease, With Up To Four Years Of Follow-Up June 4, 2017